Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion

Clinical trial NCT03685890 · RECRUITING

Trial details

NCT number: NCT03685890
Sponsor: Vastra Gotaland Region
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma In-Transit Metastasis

Start date: 2019-04-01
Primary completion: 2026-12-31
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.